|
WO2021046261A1
|
|
Allogeneic cell compositions and methods of use
|
|
WO2020132396A1
|
|
Nanotransposon compositions and methods of use
|
|
WO2020077360A1
|
|
Hematopoietic stem cell compositions, methods of making and method of use
|
|
WO2020077357A1
|
|
Compositions and methods for increasing transposition frequency
|
|
AU2019335014A1
|
|
Allogeneic cell compositions and methods of use
|
|
AU2019230192A1
|
|
CARTyrin compositions and methods for use
|
|
US2020001110A1
|
|
Compositions and methods for inducing nanoparticle-mediated microvascular embolization for tumors
|
|
WO2019126589A1
|
|
Micelles for complexation and delivery of proteins and nucleic acids
|
|
SG11202005750TA
|
|
Vcar compositions and methods for use
|
|
WO2019126578A1
|
|
Compositions and methods for directing proteins to specific loci in the genome
|
|
AU2018329741A1
|
|
Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression
|
|
US2021115453A1
|
|
Transposon system and methods of use
|
|
CN110650743A
|
|
Compositions and methods for selective depletion and replacement of hematopoietic stem cells
|
|
US2019185880A1
|
|
Transposon system and methods of use
|
|
US2019119636A1
|
|
Modified stem cell memory t cells, methods of making and methods of using same
|
|
US2019119658A1
|
|
Modified stem cell memory T cells, methods of making and methods of using same
|
|
CN110267980A
|
|
Induction type Caspase and application method
|
|
CN110199015A
|
|
Modified stem cell memory T cell, its manufacturing method and application method
|
|
AU2017296237A1
|
|
Chimeric antigen receptors (CARS) specific for MUC1 and methods for their use
|
|
AU2017296236A1
|
|
Chimeric antigen receptors and methods for use
|
